Top

Published in:

01-03-2009 | Original Paper

Nicotinamide Prevents NAD⁺ Depletion and Protects Neurons Against Excitotoxicity and Cerebral Ischemia: NAD⁺ Consumption by SIRT1 may Endanger Energetically Compromised Neurons

Authors: Dong Liu, Robert Gharavi, Michael Pitta, Marc Gleichmann, Mark P. Mattson

Published in: NeuroMolecular Medicine | Issue 1/2009

Abstract

Neurons require large amounts of energy to support their survival and function, and are therefore susceptible to excitotoxicity, a form of cell death involving bioenergetic stress that may occur in several neurological disorders including stroke and Alzheimer’s disease. Here we studied the roles of NAD⁺ bioenergetic state, and the NAD⁺-dependent enzymes SIRT1 and PARP-1, in excitotoxic neuronal death in cultured neurons and in a mouse model of focal ischemic stroke. Excitotoxic activation of NMDA receptors induced a rapid decrease of cellular NAD(P)H levels and mitochondrial membrane potential. Decreased NAD⁺ levels and poly (ADP-ribose) polymer (PAR) accumulation in nuclei were relatively early events (<4 h) that preceded the appearance of propidium iodide- and TUNEL-positive cells (markers of necrotic cell death and DNA strand breakage, respectively) which became evident by 6 h. Nicotinamide, an NAD⁺ precursor and an inhibitor of SIRT1 and PARP1, inhibited SIRT1 deacetylase activity without affecting SIRT1 protein levels. NAD⁺ levels were preserved and PAR accumulation and neuronal death induced by excitotoxic insults were attenuated in nicotinamide-treated cells. Treatment of neurons with the SIRT1 activator resveratrol did not protect them from glutamate/NMDA-induced NAD⁺ depletion and death. In a mouse model of focal cerebral ischemic stroke, NAD⁺ levels were decreased in both the contralateral and ipsilateral cortex 6 h after the onset of ischemia. Stroke resulted in dynamic changes of SIRT1 protein and activity levels which varied among brain regions. Administration of nicotinamide (200 mg/kg, i.p.) up to 1 h after the onset of ischemia elevated brain NAD⁺ levels and reduced ischemic infarct size. Our findings demonstrate that the NAD⁺ bioenergetic state is critical in determining whether neurons live or die in excitotoxic and ischemic conditions, and suggest a potential therapeutic benefit in stroke of agents that preserve cellular NAD⁺ levels. Our data further suggest that, SIRT1 is linked to bioenergetic state and stress responses in neurons, and that under conditions of reduced cellular energy levels SIRT1 enzyme activity may consume sufficient NAD⁺ to nullify any cell survival-promoting effects of its deacetylase action on protein substrates.

Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., et al. (2007). Sirt1 regulates aging and resistance to oxidative stress in the heart. Circulation Research, 100, 1512–1521. doi:10.1161/01.RES.0000267723.65696.4a.PubMedCrossRef

Anderson, R. M., Latorre-esteves, M., Neves, A. R., Lavu, S., Medvedik, O., Taylor, C., et al. (2003). Yeast life-span extension by calorie restriction is independent of NAD⁺ fluctuation. Science, 302, 2124–2126. doi:10.1126/science.1088697.PubMedCrossRef

Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A., et al. (1995). Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron, 15, 961–973. doi:10.1016/0896-6273(95)90186-8.PubMedCrossRef

Antzoulatos, E. G., & Byrne, J. H. (2004). Learning insights transmitted by glutamate. Trends in Neurosciences, 27, 555–560. doi:10.1016/j.tins.2004.06.009.PubMedCrossRef

Araki, T., Sasaki, Y., & Milbrandt, J. (2004). Increased nuclear NAD⁺ biosynthesis and SIRT1 activation prevent axonal degeneration. Science, 305, 1010–1013. doi:10.1126/science.1098014.PubMedCrossRef

Beal, M. F. (1992). Mechanisms of excitotoxicity in neurological diseases. The FASEB Journal, 6, 3338–3344.PubMed

Belenky, P., Bogan, K. L., & Brenner, C. (2006). NAD⁺ metabolism in health and disease. Trends in Biochemical Sciences, 32, 12–19. doi:10.1016/j.tibs.2006.11.006.PubMedCrossRef

Bieganowski, P., & Brenner, C. (2004). Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-handler independent route to NAD+ in fungi and humans. Cell, 117, 495–502. doi:10.1016/S0092-8674(04)00416-7.PubMedCrossRef

Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., & Sinclair, D. A. (2002). Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast Sir2 and human SIRT1. The Journal of Biological Chemistry, 277, 45099–45107. doi:10.1074/jbc.M205670200.PubMedCrossRef

Blander, G., & Guarente, L. (2004). The Sir2 family of protein deacetylases. Annual Review of Biochemistry, 73, 417–435. doi:10.1146/annurev.biochem.73.011303.073651.PubMedCrossRef

Boulares, A. H., Yakovlev, A. G., Ivanova, V., Stoica, B. A., Wang, G., Iyer, S., et al. (1999). Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis: Caspase 3-resistant parp mutant increases rates of apoptosis in transfected cells. The Journal of Biological Chemistry, 274, 22932–22940. doi:10.1074/jbc.274.33.22932.PubMedCrossRef

Brennan, A. M., Connor, J. A., & Shuttleworth, C. W. (2006). NAD(P)H fluorescence transients after synaptic activity in brain slices: predominant role of mitochondrial function. Journal of Cerebral Blood Flow and Metabolism, 26, 1389–1406. doi:10.1038/sj.jcbfm.9600292.PubMedCrossRef

Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., et al. (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science, 303, 2011–2015. doi:10.1126/science.1094637.PubMedCrossRef

Butler, R., & Bates, G. P. (2006). Histone deacetylase inhibitors as therapeutics for polyglutamine disorders. Nature Reviews. Neuroscience, 7, 784–796. doi:10.1038/nrn1989.PubMedCrossRef

Cai, A. L., Zipfel, G. J., & Sheline, C. T. (2006). Zinc neurotoxicity is dependent on intracellular NAD⁺ levels and the sirtuin pathway. The European Journal of Neuroscience, 24, 2169–2176. doi:10.1111/j.1460-9568.2006.05110.x.PubMedCrossRef

Choi, D. W., & Koh, J. Y. (1998). Zinc and brain injury. Annual Review of Neuroscience, 21, 347–375. doi:10.1146/annurev.neuro.21.1.347.PubMedCrossRef

Clement, M. V., Hirpara, J. L., Chawdhury, S. H., & Pervaiz, S. (1998). Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood, 92, 996–1002.PubMed

Cohen, H. Y., Miller, C., Bitterman, K. J., Wal, N. R., Hekking, B., Kessler, B., et al. (2004). Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science, 305, 390–392. doi:10.1126/science.1099196.PubMedCrossRef

Dawson, V. L., & Dawson, T. M. (2004). Deadly conversations: Nuclear-mitochondrial cross-talk. Journal of Bioenergetics and Biomembranes, 36, 287–294. doi:10.1023/B:JOBB.0000041755.22613.8d.PubMedCrossRef

Du, L., Zhang, X., Han, Y. Y., Burke, N. A., Kochanek, P. M., Watkins, S. C., et al. (2003). Intra-mitochondrial poly(ADP-ribosylation) contributes to NAD⁺ depletion and cell death induced by oxidative stress. The Journal of Biological Chemistry, 278, 18426–18433. doi:10.1074/jbc.M301295200.PubMedCrossRef

Eng, J., Lynch, R. M., & Balaban, R. S. (1989). Nicotinamide adenine dinucleotide fluorescence spectroscopy and imaging of isolated myocytes. Biophysical Journal, 55, 621–630. doi:10.1016/S0006-3495(89)82859-0.PubMedCrossRef

Fabrizio, P., Gattazzo, C., Battistella, L., Wei, M., Cheng, C., McGrew, K., et al. (2005). Sir2 blocks extreme life-span extension. Cell, 18, 655–667. doi:10.1016/j.cell.2005.08.042.CrossRef

Feng, Y., Paul, I. A., & LeBlanc, M. H. (2006). Nicotinamide reduces hypoxic ischemic brain injury in the newborn rat. Brain Research Bulletin, 69, 117–122. doi:10.1016/j.brainresbull.2005.11.011.PubMedCrossRef

Gao, X., Xu, Y. X., Divine, G., Janakiraman, N., Chapman, R. A., & Gautam, S. C. (2002). Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. The Journal of Nutrition, 132, 2076–2081.PubMed

Gill, R., Andine, P., Hillerd, L., Persson, L., & Hagberg, H. (1992). The effect of MK-801 on cortical spreading depression in the penumbral zone following focal ischemia in the rat. Journal of Cerebral Blood Flow and Metabolism, 12, 371–379.PubMed

Green, K. N., Steffan, J. S., Martinez-Coria, H., Sun, X., Schreiber, S. S., Thompson, L. M., et al. (2008). Nicotinamide restores cognition in Alzheimer’s disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. Journal of Neuroscience, 28, 11500–11510. doi:10.1523/JNEUROSCI.3203-08.2008.PubMedCrossRef

Greene, J. G., & Greenamyre, J. T. (1996). Bioenergetics and glutamate excitotoxicity. Progress in Neurobiology, 48, 613–634. doi:10.1016/0301-0082(96)00006-8.PubMedCrossRef

Grubisha, O., Smith, B. C., & Denu, J. M. (2005). Small molecule regulation of sir2 protein deacetylase. FEBS, 272, 4607–4616. doi:10.1111/j.1742-4658.2005.04862.x.CrossRef

Ha, H. C., & Snyder, S. H. (2000). Poly(ADP-ribose) polymerase-1 in the nervous system. Neurobiology of Disease, 7, 225–239. doi:10.1006/nbdi.2000.0324.PubMedCrossRef

Hata, R., Maeda, K., Hermann, D., Mies, G., & Hossmann, K. A. (2000). Dynamics of regional brain metabolism and gene expression after middle cerebral artery occlusion. Journal of Cerebral Blood Flow and Metabolism, 20, 306–315. doi:10.1097/00004647-200002000-00012.PubMed

Herceg, Z., & Wang, Z. Q. (1999). Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis. Molecular and Cellular Biology, 19, 5124–5133.PubMed

Hinz, M., Katsilambros, N., Maier, V., Schatz, H., & Pfeiffer, E. F. (1973). Significance of streptozotocin induced nicotinamide-adenine-dinucleotide (NAD⁺) degradation in mouse pancreatic islets. FEBS Letters, 30, 225–230. doi:10.1016/0014-5793(73)80656-8.PubMedCrossRef

Hossmann, K. A. (2003). Glutamate hypothesis of stroke. Fortschritte der Neurologie, Psychiatrie, und ihrer Grenzgebiete, 71(Suppl 1), S10. doi:10.1055/s-2003-40500.

Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., & Wood, J. G. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 425, 191–196. doi:10.1038/nature01960.PubMedCrossRef

Hyun, D. H., Hunt, N. D., Emerson, S. S., Hernandez, J. O., Mattson, M. P., & de Cabo, R. (2007). Up-regulation of plasma membrane-associated redox activities in neuronal cells lacking functional mitochondria. Journal of Neurochemistry, 100, 1364–1374. doi:10.1111/j.1471-4159.2006.04411.x.PubMedCrossRef

Imai, S., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000). Transcriptional silencing and longevity protein Sir2 is an NAD⁺-dependent histone deacetylase. Nature, 403, 795–800. doi:10.1038/35001622.PubMedCrossRef

Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., & Poirier, G. G. (1993). Specific cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Research, 53, 3976–3985.PubMed

Kauppinen, T. M., & Swanson, R. A. (2007). The role of poly(ADP-ribose) polymerase-1 in CNS disease. Neuroscience, 145, 1267–1272. doi:10.1016/j.neuroscience.2006.09.034.PubMedCrossRef

Klaidman, L., Morales, M., Kem, S., Yang, J., Chang, M. L., & Adams, J. D. (2003). Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD⁺, as a PARP inhibitor and by partial restoration of mitochondrial function. Pharmacology, 69, 150–157. doi:10.1159/000072668.PubMedCrossRef

Kobayashi, Y., Furukawa-Hibi, Y., Chen, C., Horio, Y., Isobe, K., Ikeda, K., et al. (2005). SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. International Journal of Molecular Medicine, 16, 237–243.PubMed

Kolthur-Seetharam, U., Dantzer, F., McBurney, M. W., de Murcia, G., & Sassone-Corsi, P. (2006). Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage. Cell Cycle, 5, 873–877.PubMed

Landry, J., Sutton, A., Tafrov, S. T., Heller, R. C., Stebbins, J., Pillus, L., et al. (2000). The silencing protein SIR2 and its homologs are NAD⁺-dependent protein deacetylases. Proceedings of the National Academy of Sciences of the United States of America, 97, 5807–5811. doi:10.1073/pnas.110148297.PubMedCrossRef

Langley, B., Gensert, J. M., Beal, M. F., & Ratan, R. R. (2005). Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Current Drug Targets. CNS Neurological Disorders, 4, 41–50.PubMedCrossRef

Lee, J. B., Grabb, M. C., Zipfel, G. J., & Choi, D. W. (2000). Brain tissue responses to ischemia. The Journal of Clinical Investigation, 106, 723–731. doi:10.1172/JCI11003.PubMedCrossRef

Lisa, F. D., Menabo, R., Canton, M., Baria, M., & Bernardi, P. (2001). Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytesin postischemic reperfusion of the heart. The Journal of Biological Chemistry, 276, 2571–2575. doi:10.1074/jbc.M006825200.PubMedCrossRef

Liu, D., Chan, S. L., de Souza-Pinto, N. C., Slevin, J. R., Wersto, R. P., Zhan, M., et al. (2006). Mitochondrial UCP4 mediates an adaptive shift in energy metabolism and increases the resistance of neurons to metabolic and oxidative stress. Neuromolecular Medicine, 8, 389–414. doi:10.1385/NMM:8:3:389.PubMedCrossRef

Liu, D., Lu, C., Wan, R., Auyeung, W. W., & Mattson, M. P. (2002). Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome C. Journal of Cerebral Blood Flow and Metabolism, 22, 431–433. doi:10.1097/00004647-200204000-00007.PubMed

Liu, D., Pitta, M., & Mattson, M. (2008). Preventing NAD+ depletion protects neurons against excitotoxicity: Bioenergetic effects of mild mitochondrial uncoupling, caloric restriction. Annals of the New York Academy of Sciences, 1147, 275–282.PubMedCrossRef

Liu, D., Smith, C. L., Barone, F. C., Ellison, J. A., Lysko, P. G., Li, K., et al. (1999). Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain. Molecular Brain Research, 68, 29–41. doi:10.1016/S0169-328X(99)00063-7.PubMedCrossRef

Matthews, R. T., Ferrante, R. J., Klivenyi, P., Yang, L., Klein, A. M., Mueller, G., et al. (1999). Creatine and cyclocreatine attenuate MPTP neurotoxicity. Experimental Neurology, 157, 142–149. doi:10.1006/exnr.1999.7049.PubMedCrossRef

Matthews, R. T., Yang, L., Jenkins, B. G., Ferrante, R. J., Rosen, B. R., Kaddurah-Daouk, R., et al. (1998). Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington’s disease. Journal of Neuroscience, 18, 156–163.PubMed

Mattson, M. P. (2003). Excitotoxic and excitoprotective mechanisms: Abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Medicine, 3, 65–94. doi:10.1385/NMM:3:2:65.PubMedCrossRef

Mattson, M. P., Barger, S. W., Begley, J. G., & Mark, R. J. (1995). Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods in Cell Biology, 46, 187–216. doi:10.1016/S0091-679X(08)61930-5.PubMedCrossRef

Mattson, M. P., & Liu, D. (2002). Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. Neuromolecular Medicine, 2, 215–231. doi:10.1385/NMM:2:2:215.PubMedCrossRef

McBurney, M. W., Yang, X., Jardine, K., Hixon, M., Boekelheide, K., Webb, J. R., et al. (2003). The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Molecular and Cellular Biology, 23, 38–54. doi:10.1128/MCB.23.1.38-54.2003.PubMedCrossRef

Ohsawa, S., & Miura, M. (2006). Caspase-mediated changes in Sir2α during apoptosis. FEBS Letters, 580, 5875–5879. doi:10.1016/j.febslet.2006.09.051.PubMedCrossRef

Pieper, A. A., Blackshaw, S., Clements, E. E., Daniel, J., Brat, D. J., Krug, D. K., et al. (2000). Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission. Proceedings of the National Academy of Sciences of the United States of America, 97, 1845–1850. doi:10.1073/pnas.97.4.1845.PubMedCrossRef

Pillai, J. B., Isbatan, A., Imai, S., & Gupta, M. P. (2005). Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD⁺ depletion and reduced sir2α deacetylase activity. The Journal of Biological Chemistry, 280, 43121–43130. doi:10.1074/jbc.M506162200.PubMedCrossRef

Raval, A. P., Dave, K. R., & Perez-Pinzon, M. A. (2006). Resveratrol mimics ischemic preconditioning in the brain. Journal of Cerebral Blood Flow and Metabolism, 26, 1141–1147.PubMed

Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005). Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature, 434, 113–118. doi:10.1038/nature03354.PubMedCrossRef

Sadanaga-Akiyoshi, F., Yao, H., Tanuma, S., Nakahara, T., Hong, J. S., Ibayashi, S., et al. (2003). Nicotinamide attenuates focal ischemic brain injury in rats: With special reference to changes in nicotinamide and NAD+ levels in ischemic core and penumbra. Neurochemical Research, 28, 1227–1234. doi:10.1023/A:1024236614015.PubMedCrossRef

Sauve, A. A., Moir, R. M., Schramm, V. L., & Willis, I. M. (2005). Chemical activation of sir2-dependent silencing by relief of nicotinamide inhibition. Molecular Cell, 17, 595–601. doi:10.1016/j.molcel.2004.12.032.PubMedCrossRef

Schmidt, M. T., Smith, B. C., Jackson, M. D., & Denu, J. M. (2004). Coenzyme specificity of Sir2 protein deacetylases: Implications for physiological regulation. The Journal of Biological Chemistry, 279, 40122–40129. doi:10.1074/jbc.M407484200.PubMedCrossRef

Schulz, J. B., Henshaw, D. R., Matthews, R. T., & Beal, M. F. (1995). Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity. Experimental Neurology, 132, 279–283. doi:10.1016/0014-4886(95)90033-0.PubMedCrossRef

Sheline, C. T., Behrens, M. M., & Choi, D. W. (2000). Zinc-induced cortical neuronal death: contribution of energy failure attributable to loss of NAD⁺ and inhibition of glycolysis. The Journal of Neuroscience, 20, 3139–3146.PubMed

Soane, L., Kahraman, S., Kristian, T., & Fiskum, G. (2007). Mechanisms of impaired mitochondrial energy metabolism in acute and chronic neurodegenerative disorders. Journal of Neuroscience Research, 85, 3407–3415. doi:10.1002/jnr.21498.PubMedCrossRef

Sullivan, P. G., Geiger, J. D., Mattson, M. P., & Scheff, S. W. (2000). Dietary supplement creatine protects against traumatic brain injury. Annals of Neurology, 48, 723–729. doi:10.1002/1531-8249(200011)48:5<723::AID-ANA5>3.0.CO;2-W.PubMedCrossRef

Tanner, K. G., Landry, J., Sternglanz, R., & Denu, J. M. (2000). Silent information regulator 2 family of NAD-dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proceedings of the National Academy of Sciences of the United States of America, 97, 14178–14182. doi:10.1073/pnas.250422697.PubMedCrossRef

Tarnopolsky, M. A., & Beal, M. F. (2001). Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Annals of Neurology, 49, 561–574. doi:10.1002/ana.1028.PubMedCrossRef

Virag, L., & Szabo, C. (2002). The therapeutic potential of poly (ADP-ribose) polymerase inhibitors. Pharmacological Reviews, 54, 375–429. doi:10.1124/pr.54.3.375.PubMedCrossRef

Winfree, C. J., Baker, C. J., Connoly, E. S., Fiore, A. J., & Solomon, R. A. (1996). Mild hypothermia reduces penumbral glutamate levels in the rat permanent focal cerebral ischemia model. Neurosurgery, 38, 1216–1222. doi:10.1097/00006123-199606000-00034.PubMedCrossRef

Woodley, C. L., & Gupta, N. K. (1971). New enzyme cycling method for determination of oxidized and reduced nicotinamide adenine dinucleotide. Analytical Biochemistry, 43, 341–348.PubMedCrossRef

Yang, J., Klaidman, L. K., Chang, M. L., Kem, S., Sugawara, T., Chan, P., et al. (2002). Nicotinamide therapy protects against both necrosis and apoptosis in a stroke model. Pharmacology, Biochemistry, and Behavior, 73, 901–910. doi:10.1016/S0091-3057(02)00939-5.PubMedCrossRef

Yang, T., & Sauve, A. A. (2006). NAD⁺ metabolism and sirtuins: Metabolic regulation of protein deacetylation in stress and toxicity. The AAPS Journal, 8, 632–643. doi:10.1208/aapsj080472.CrossRef

Title: Nicotinamide Prevents NAD+ Depletion and Protects Neurons Against Excitotoxicity and Cerebral Ischemia: NAD+ Consumption by SIRT1 may Endanger Energetically Compromised Neurons
Authors: Dong Liu
Robert Gharavi
Michael Pitta
Marc Gleichmann
Mark P. Mattson
Publication date: 01-03-2009
Publisher: Humana Press Inc
Published in: NeuroMolecular Medicine / Issue 1/2009
Print ISSN: 1535-1084
Electronic ISSN: 1559-1174
DOI: https://doi.org/10.1007/s12017-009-8058-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Nicotinamide Prevents NAD⁺ Depletion and Protects Neurons Against Excitotoxicity and Cerebral Ischemia: NAD⁺ Consumption by SIRT1 may Endanger Energetically Compromised Neurons

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2009

Common Variations in 4p Locus are Related to Male Completed Suicide

Human BDNF Isoforms are Differentially Expressed in Cocaine Addicts and are Sorted to the Regulated Secretory Pathway Independent of the Met66 Substitution

AAV-mediated Local Delivery of Interferon-β for the Treatment of Retinoblastoma in Preclinical Models

Voltammetric Bioassay of Caffeine using Sensor Implant